Modifica secondaria di un'autorizzazione all'immissione in commercio di una specialita' medicinale per uso umano. Modifica apportata ai sensi del Decreto Legislativo 29 dicembre 2007,n. 274 Titolare AIC: Dr. Willmar Schwabe GmbH & Co. KG, con sede in Willmar-Schwabe-Str. 476227 Karlsruhe Germany Specialita' Medicinale: NERVAXON 300 mg compresse rivestite Confezioni e numero AIC: 45 compresse - AIC n. 033894041; 90 compresse - AIC n. 033894066; 15 compresse - AIC n. 033894015; 60 compresse - AIC n. 033894054; 100 compresse - AIC n. 033894078; 30 compresse - AIC n. 033894039; 20 compresse - AIC n. 033894027 Codice Pratica N1A/2011/820 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.I.d.1.b.1) Change to more restrictive storage conditions of the active substance where no Ph. Eur. Certificate of Suitability covering the retest period is part of the approved dossier: Do not store above 25°C Codice Pratica N1B/2011/641 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IB B.I.d.1.a)4. Change in the re-test period of the active substance where no Ph. Eur. Certificate of Suitability covering the retest period is part of the approved dossier, Extension of the Re-test period from 6 months to 9 months Codice Pratica N1A/2011/ 817 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA - B.III.2.c) Change to comply with Ph. Eur. - Change in specifications from a national pharmacopoeia of a Member State to the Ph. Eur: St. John's wort from DAC and additional specifications to Ph. Eur. and additional specifications. Codice Pratica N1A/2011/821 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.II.b.4 - Change in the batch size of the finished product, a) Up to 10-fold compared to the currently approved batch size: from 562 kg to 618.2 kg Codice Pratica N1A/2011/824 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.III.2.c) Change to comply with Ph. Eur. - Change in specifications from a national pharmacopoeia of a Member State to the Ph. Eur: Pregelatinized maize starch from BP 1993 to Ph. Eur. (current version) Codice Pratica N1A/2011/825 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.II.c.1 Change in the specification parameters and/or limits of an excipient; a) Tightening of in-process limits: Antifoam emulsion, from in-house specification to USP (current version) Codice Pratica N1A/2011/816 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active substance or change in the manufacturer of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier; a) The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer: additional supplier of St. John's: APD GmbH Codice Pratica N1A/2011/827 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.II.e.2 Change in the specification parameters and/or limits of the immediate packaging of the finished product - a) Tightening of specification limits: Container Closure System Blister material: from PVC foil and aluminium foil or PVC/PVDC foil and aluminium foil to PVC/PVDC foil and aluminium foil Codice Pratica N1A/2011/823 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.II.c.1 Change in the specification parameters and/or limits of an excipient; a) Tightening of in-process limit for the excipient Iron oxide yellow E172 Codice Pratica N1A/2011/822 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product, c) Deletion of a non-significant in-process test - Control of Critical Steps Ready for compressing mixture: Particle size extract: not specified Codice Pratica N1A/2011/818 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA - B.I.a.2a) Minor change in the manufacturing process of the active substance: addition of grinding the drug substance bevor particle size analysis - St. John's wort dry extract Codice Pratica N1A/2011/819 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.III.2 Change to comply with Ph. Eur. - a) Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. - 1. Active substance: St. John's wort dry extract from in-house specification to Ph. Eur. (current version) and additional specifications Codice Pratica N1A/2011/826 Modifica apportata ai sensi del Regolamento (CE) 1234/2008 variazione Tipo IA B.II.d.1 Change in the specification parameters and/or limits of the finished product; c) Addition of a new specification parameter to the specification with its corresponding test method: Flavonoids greater than or equal 18.0 mg/c.t - Rutin greater than or equal 4.5 mg / c.t. I lotti gia' prodotti alla data della pubblicazione in Gazzetta Ufficiale possono essere mantenuti in commercio fino alla data di scadenza indicata in etichetta. Head of International Regulatory & Scientific Affairs Dott. U. Mathes T11ADD8534